Cargando…

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review

INTRODUCTION: This scoping review includes studies on pharmaceutical access, shortages, generics, availability, pharmacoeconomics, and pricing restrictions. The study’s findings may aid in developing excellent pharmaceutical and access policies in the country. OBJECTIVE: To conduct a scoping review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirza, Ahmer Hameed, Alqasomi, Abdulmajeed, El-Dahiyat, Faris, Babar, Zaheer-Ud-Din
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356550/ https://www.ncbi.nlm.nih.gov/pubmed/37484573 http://dx.doi.org/10.2147/IPRP.S410262

Ejemplares similares

Pharmacy practice and clinical pharmacy research in the Middle East: a scoping review of studies from Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, United Arab Emirates, and Yemen
por: Obaid, Daneh, et al.
Publicado: (2022)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

The community pharmacy practice change towards patient-centered care in Saudi Arabia: a qualitative perspective
por: Rasheed, Muhammad Kamran, et al.
Publicado: (2020)

Impact of an educational program on community pharmacist’s preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia
por: Rasheed, Muhammad Kamran, et al.
Publicado: (2023)

Exploring the factors impacting physicians’ attitudes toward health information exchange with patients in Jordanian hospitals
por: Dahiyat, Emad, et al.
Publicado: (2023)

Recommendations to improve pharmacy practice research in the Middle Eastern Arab countries
por: Obaid, Daneh, et al.
Publicado: (2021)

Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults
por: El-Dahiyat, Faris, et al.
Publicado: (2020)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries?
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2010)

Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit!
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2013)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Understanding the factors influencing healthcare providers’ burnout during the outbreak of COVID-19 in Jordanian hospitals
por: Algunmeeyn, Abdullah, et al.
Publicado: (2020)

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
por: Gammie, Todd, et al.
Publicado: (2015)

Community pharmacist’s preparedness to provide patient-centred care in Saudi Arabia
por: Rasheed, Muhammad Kamran, et al.
Publicado: (2023)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries
por: Perehudoff, Katrina, et al.
Publicado: (2020)

New Zealand consumers’ perceptions of private insurance for pharmaceuticals
por: Ragupathy, Rajan, et al.
Publicado: (2014)

Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia
por: Abdulsalim, Suhaj, et al.
Publicado: (2023)

Human resources health supply chains and access to essential medicines
por: Brown, Andrew, et al.
Publicado: (2014)

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012)

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2016)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study
por: Zia, Nadeem, et al.
Publicado: (2021)

Policy cooperation and interface issues
por: Vogler, Sabine, et al.
Publicado: (2015)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Policies beyond the crisis: lesson learned
por: Vogler, Sabine, et al.
Publicado: (2015)

National medicines policy development, Saudi Arabia
por: Almoteiry, Khalid, et al.
Publicado: (2022)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2022)

Correction to: Online medication purchasing during the Covid-19 pandemic: a pilot study from the United Arab Emirates
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2021)

Online medication purchasing during the Covid-19 pandemic: potential risks to patient safety and the urgent need to develop more rigorous controls for purchasing online medications, a pilot study from the United Arab Emirates
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2021)

Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2015)

Qualitative Exploration of Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes in Saudi Arabia
por: Alodhaib, Ghaida, et al.
Publicado: (2021)

A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19
por: Bukhari, Nadia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q556eqjpp42qlsda6sq6mckpgp